Skip to content

Clinical trials

Observational Hyperparathyroidism, Secondary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperparathyroidism, Secondary Phase: Observational Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20071
20083
20091
20102
20114
20121
20142
20161
20173
20181
20191
20202
20212
20221
20234
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Unknown status4
Recruiting3
Active, not recruiting1
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie (prior sponsor, Abbott)9
Abbott2
Amgen2
Assiut University1
Beijing Friendship Hospital1
Benha University1
Boryung Pharmaceutical Co., Ltd1
Centre Hospitalier Universitaire de Saint Etienne1
China-Japan Friendship Hospital1
Chunling Jiang1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperparathyroidism, Secondary36
Renal Insufficiency, Chronic15
Kidney Failure, Chronic8
Chronic Kidney Disease-Mineral and Bone Disorder7
Fractures, Bone2
Hyperparathyroidism2
Hyperparathyroidism, Primary2
Bone Diseases1
Bone Diseases, Metabolic1
Calcinosis1

Trials

Showing 76 to 36 of 36. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.